Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Protocols for CRISPR-Cas9 Screening in Lymphoma Cell Lines.

Webster DE, Roulland S, Phelan JD.

Methods Mol Biol. 2019;1956:337-350. doi: 10.1007/978-1-4939-9151-8_16.

PMID:
30779043
2.

A multiprotein supercomplex controlling oncogenic signalling in lymphoma.

Phelan JD, Young RM, Webster DE, Roulland S, Wright GW, Kasbekar M, Shaffer AL 3rd, Ceribelli M, Wang JQ, Schmitz R, Nakagawa M, Bachy E, Huang DW, Ji Y, Chen L, Yang Y, Zhao H, Yu X, Xu W, Palisoc MM, Valadez RR, Davies-Hill T, Wilson WH, Chan WC, Jaffe ES, Gascoyne RD, Campo E, Rosenwald A, Ott G, Delabie J, Rimsza LM, Rodriguez FJ, Estephan F, Holdhoff M, Kruhlak MJ, Hewitt SM, Thomas CJ, Pittaluga S, Oellerich T, Staudt LM.

Nature. 2018 Aug;560(7718):387-391. doi: 10.1038/s41586-018-0290-0. Epub 2018 Jun 20.

3.

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.

Schmitz R, Wright GW, Huang DW, Johnson CA, Phelan JD, Wang JQ, Roulland S, Kasbekar M, Young RM, Shaffer AL, Hodson DJ, Xiao W, Yu X, Yang Y, Zhao H, Xu W, Liu X, Zhou B, Du W, Chan WC, Jaffe ES, Gascoyne RD, Connors JM, Campo E, Lopez-Guillermo A, Rosenwald A, Ott G, Delabie J, Rimsza LM, Tay Kuang Wei K, Zelenetz AD, Leonard JP, Bartlett NL, Tran B, Shetty J, Zhao Y, Soppet DR, Pittaluga S, Wilson WH, Staudt LM.

N Engl J Med. 2018 Apr 12;378(15):1396-1407. doi: 10.1056/NEJMoa1801445.

4.

From hepatitis C virus infection to B-cell lymphoma.

Couronné L, Bachy E, Roulland S, Nadel B, Davi F, Armand M, Canioni D, Michot JM, Visco C, Arcaini L, Besson C, Hermine O.

Ann Oncol. 2018 Jan 1;29(1):92-100. doi: 10.1093/annonc/mdx635.

PMID:
29045541
5.

Prediagnostic circulating concentrations of plasma insulin-like growth factor-I and risk of lymphoma in the European Prospective Investigation into Cancer and Nutrition.

Perez-Cornago A, Appleby PN, Tipper S, Key TJ, Allen NE, Nieters A, Vermeulen R, Roulland S, Casabonne D, Kaaks R, Fortner RT, Boeing H, Trichopoulou A, La Vecchia C, Klinaki E, Hansen L, Tjønneland A, Bonnet F, Fagherazzi G, Boutron-Ruault MC, Pala V, Masala G, Sacerdote C, Peeters PH, Bueno-de-Mesquita HB, Weiderpass E, Dorronsoro M, Quirós JR, Barricarte A, Gavrila D, Agudo A, Borgquist S, Rosendahl AH, Melin B, Wareham N, Khaw KT, Gunter M, Riboli E, Vineis P, Travis RC.

Int J Cancer. 2017 Mar 1;140(5):1111-1118. doi: 10.1002/ijc.30528. Epub 2016 Dec 27.

6.

BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice.

Hamouda MA, Jacquel A, Robert G, Puissant A, Richez V, Cassel R, Fenouille N, Roulland S, Gilleron J, Griessinger E, Dubois A, Bailly-Maitre B, Goncalves D, Mallavialle A, Colosetti P, Marchetti S, Amiot M, Gomez-Bougie P, Rochet N, Deckert M, Avet-Loiseau H, Hofman P, Karsenti JM, Jeandel PY, Blin-Wakkach C, Nadel B, Cluzeau T, Anderson KC, Fuzibet JG, Auberger P, Luciano F.

J Exp Med. 2016 Aug 22;213(9):1705-22. doi: 10.1084/jem.20150983. Epub 2016 Jul 25.

7.

In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas.

Canioni D, Michot JM, Rabiega P, Molina TJ, Charlotte F, Lazure T, Davi F, Settegrana C, Berger F, Alric L, Cacoub P, Terrier B, Suarez F, Sibon D, Dupuis J, Feray C, Tilly H, Pol S, Deau Fischer B, Roulland S, Thieblemont C, Leblond V, Carrat F, Hermine O, Besson C; national ANRS HC13 LymphoC study.

PLoS One. 2016 Jun 3;11(6):e0156384. doi: 10.1371/journal.pone.0156384. eCollection 2016.

8.

Determinants of the t(14;18) translocation and their role in t(14;18)-positive follicular lymphoma.

Kelly RS, Roulland S, Morgado E, Sungalee S, Jouve N, Tumino R, Krogh V, Panico S, Polidoro S, Masala G, Sánchez MJ, Chirlaque MD, Sala N, Gurrea AB, Dorronsoro M, Travis RC, Riboli E, Gunter M, Murphy N, Vermeulen R, Bueno-de-Mesquita HB, Peeters PH, Trichopoulou A, Trichopoulos D, Lagiou P, Nieters A, Canzian F, Kaaks R, Boeing H, Weiderpass E, Stocks T, Melin B, Overvad K, Tjønneland A, Olsen A, Brennan P, Johansson M, Nadel B, Vineis P.

Cancer Causes Control. 2015 Dec;26(12):1845-55. doi: 10.1007/s10552-015-0677-2. Epub 2015 Sep 30.

9.

Premalignant cell dynamics in indolent B-cell malignancies.

Milpied P, Nadel B, Roulland S.

Curr Opin Hematol. 2015 Jul;22(4):388-96. doi: 10.1097/MOH.0000000000000159. Review.

PMID:
26049761
10.

[Follicular lymphoma: a history of perversion of immunological memory].

Roulland S, Nadel B.

Med Sci (Paris). 2015 Apr;31(4):360-2. doi: 10.1051/medsci/20153104005. Epub 2015 May 8. French. No abstract available.

11.

Lag times between lymphoproliferative disorder and clinical diagnosis of chronic lymphocytic leukemia: a prospective analysis using plasma soluble CD23.

Kaaks R, Sookthai D, Łuczyńska A, Oakes CC, Becker S, Johnson T, Johansson A, Melin B, Sjöberg K, Trichopoulos D, Trichopoulou A, Lagiou P, Mattiello A, Tumino R, Masala G, Agnoli C, Boeing H, Aleksandrova K, Brennan P, Franceschi S, Roulland S, Casabonne D, de Sanjose S, Sánchez MJ, Huerta JM, Ardanaz E, Sala N, Overvad K, Tjønneland A, Halkjær J, Weiderpass E, Bueno-de-Mesquita HB, Vermeulen R, Peeters PH, Vineis P, Kelly RS, Khaw KT, Travis RC, Key TJ, Riboli E, Nieters A.

Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):538-45. doi: 10.1158/1055-9965.EPI-14-1107. Epub 2014 Dec 26.

12.

Contiguous follicular lymphoma and follicular lymphoma in situ harboring N-glycosylated sites.

Mamessier E, Drevet C, Broussais-Guillaumot F, Mollichella ML, Garciaz S, Roulland S, Benchetrit M, Nadel B, Xerri L.

Haematologica. 2015 Apr;100(4):e155-7. doi: 10.3324/haematol.2014.115782. Epub 2014 Dec 19. No abstract available.

13.

Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression.

Sungalee S, Mamessier E, Morgado E, Grégoire E, Brohawn PZ, Morehouse CA, Jouve N, Monvoisin C, Menard C, Debroas G, Faroudi M, Mechin V, Navarro JM, Drevet C, Eberle FC, Chasson L, Baudimont F, Mancini SJ, Tellier J, Picquenot JM, Kelly R, Vineis P, Ruminy P, Chetaille B, Jaffe ES, Schiff C, Hardwigsen J, Tice DA, Higgs BW, Tarte K, Nadel B, Roulland S.

J Clin Invest. 2014 Dec;124(12):5337-51. doi: 10.1172/JCI72415. Epub 2014 Nov 10.

14.

t(14;18) Translocation: A predictive blood biomarker for follicular lymphoma.

Roulland S, Kelly RS, Morgado E, Sungalee S, Solal-Celigny P, Colombat P, Jouve N, Palli D, Pala V, Tumino R, Panico S, Sacerdote C, Quirós JR, Gonzáles CA, Sánchez MJ, Dorronsoro M, Navarro C, Barricarte A, Tjønneland A, Olsen A, Overvad K, Canzian F, Kaaks R, Boeing H, Drogan D, Nieters A, Clavel-Chapelon F, Trichopoulou A, Trichopoulos D, Lagiou P, Bueno-de-Mesquita HB, Peeters PH, Vermeulen R, Hallmans G, Melin B, Borgquist S, Carlson J, Lund E, Weiderpass E, Khaw KT, Wareham N, Key TJ, Travis RC, Ferrari P, Romieu I, Riboli E, Salles G, Vineis P, Nadel B.

J Clin Oncol. 2014 May 1;32(13):1347-55. doi: 10.1200/JCO.2013.52.8190. Epub 2014 Mar 31.

PMID:
24687831
15.

Human t(14;18)positive germinal center B cells: a new step in follicular lymphoma pathogenesis?

Tellier J, Menard C, Roulland S, Martin N, Monvoisin C, Chasson L, Nadel B, Gaulard P, Schiff C, Tarte K.

Blood. 2014 May 29;123(22):3462-5. doi: 10.1182/blood-2013-12-545954. Epub 2014 Mar 27.

PMID:
24677543
16.

Early lesions of follicular lymphoma: a genetic perspective.

Mamessier E, Song JY, Eberle FC, Pack S, Drevet C, Chetaille B, Abdullaev Z, Adelaïde J, Birnbaum D, Chaffanet M, Pittaluga S, Roulland S, Chott A, Jaffe ES, Nadel B.

Haematologica. 2014 Mar;99(3):481-8. doi: 10.3324/haematol.2013.094474. Epub 2013 Oct 25.

17.

Early steps of follicular lymphoma pathogenesis.

Roulland S, Faroudi M, Mamessier E, Sungalee S, Salles G, Nadel B.

Adv Immunol. 2011;111:1-46. doi: 10.1016/B978-0-12-385991-4.00001-5. Review.

PMID:
21970951
18.

Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia.

Bonnet M, Loosveld M, Montpellier B, Navarro JM, Quilichini B, Picard C, Di Cristofaro J, Bagnis C, Fossat C, Hernandez L, Mamessier E, Roulland S, Morgado E, Formisano-Tréziny C, Dik WA, Langerak AW, Prebet T, Vey N, Michel G, Gabert J, Soulier J, Macintyre EA, Asnafi V, Payet-Bornet D, Nadel B.

Blood. 2011 Jun 16;117(24):6650-9. doi: 10.1182/blood-2011-02-336842. Epub 2011 Apr 28.

PMID:
21527520
19.

[The profiling era: towards innovative approaches for tailored therapy].

Roulland S, Nadel B.

Med Sci (Paris). 2009 Jun-Jul;25(6-7):553-5. doi: 10.1051/medsci/2009256-7553. French. No abstract available.

20.

Agricultural pesticide exposure and the molecular connection to lymphomagenesis.

Agopian J, Navarro JM, Gac AC, Lecluse Y, Briand M, Grenot P, Gauduchon P, Ruminy P, Lebailly P, Nadel B, Roulland S.

J Exp Med. 2009 Jul 6;206(7):1473-83. doi: 10.1084/jem.20082842. Epub 2009 Jun 8.

21.

t(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individuals.

Lecluse Y, Lebailly P, Roulland S, Gac AC, Nadel B, Gauduchon P.

Leukemia. 2009 Jun;23(6):1190-3. doi: 10.1038/leu.2009.31. Epub 2009 Feb 26. No abstract available.

PMID:
19242498
22.

Pathophysiological aspects of memory B-cell development.

Roulland S, Suarez F, Hermine O, Nadel B.

Trends Immunol. 2008 Jan;29(1):25-33. Epub 2007 Dec 3. Review.

PMID:
18061541
23.

In vivo reinsertion of excised episomes by the V(D)J recombinase: a potential threat to genomic stability.

Vanura K, Montpellier B, Le T, Spicuglia S, Navarro JM, Cabaud O, Roulland S, Vachez E, Prinz I, Ferrier P, Marculescu R, Jäger U, Nadel B.

PLoS Biol. 2007 Mar;5(3):e43.

24.

Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis.

Roulland S, Navarro JM, Grenot P, Milili M, Agopian J, Montpellier B, Gauduchon P, Lebailly P, Schiff C, Nadel B.

J Exp Med. 2006 Oct 30;203(11):2425-31. Epub 2006 Oct 16. Erratum in: J Exp Med. 2006 Oct 30;203(11):2563.

25.

Recombinase, chromosomal translocations and lymphoid neoplasia: targeting mistakes and repair failures.

Marculescu R, Vanura K, Montpellier B, Roulland S, Le T, Navarro JM, Jäger U, McBlane F, Nadel B.

DNA Repair (Amst). 2006 Sep 8;5(9-10):1246-58. Epub 2006 Jun 23. Review.

PMID:
16798110
26.

Long-term clonal persistence and evolution of t(14;18)-bearing B cells in healthy individuals.

Roulland S, Lebailly P, Lecluse Y, Heutte N, Nadel B, Gauduchon P.

Leukemia. 2006 Jan;20(1):158-62. No abstract available.

PMID:
16307019
27.

Characterization of the t(14;18) BCL2-IGH translocation in farmers occupationally exposed to pesticides.

Roulland S, Lebailly P, Lecluse Y, Briand M, Pottier D, Gauduchon P.

Cancer Res. 2004 Mar 15;64(6):2264-9.

28.

Correspondence re: Welzel et al, Cancer Res, 61: 1629-1636.

Roulland S, Lebailly P, Gauduchon P.

Cancer Res. 2003 Apr 1;63(7):1722-3. No abstract available.

29.

BCL-2/JH translocation in peripheral blood lymphocytes of unexposed individuals: lack of seasonal variations in frequency and molecular features.

Roulland S, Lebailly P, Roussel G, Briand M, Cappellen D, Pottier D, Hardouin A, Troussard X, Bastard C, Henry-Amar M, Gauduchon P.

Int J Cancer. 2003 May 10;104(6):695-8.

30.

No BCL-2 protein over expression but BCL-2/IgH rearrangements in B cells of patients with persistent polyclonal B-cell lymphocytosis.

Lancry L, Roulland S, Roué G, Mossafa H, Salaün V, Chèze S, Gauduchon P, Hardouin A, Sola B, Troussard X.

Hematol J. 2001;2(4):228-33.

PMID:
11920254

Supplemental Content

Loading ...
Support Center